These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34889470)

  • 1. Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis.
    Albayrak N; Dirix V; Aerts L; Van Praet A; Godefroid A; Dauby N; Windey P; Muylle I; Mascart F; Corbière V
    J Leukoc Biol; 2022 May; 111(5):1031-1042. PubMed ID: 34889470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly cytotoxic terminally differentiated CD56
    Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
    Blood Adv; 2018 May; 2(10):1101-1114. PubMed ID: 29764843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the diversity of circulating natural killer cells between active tuberculosis and latent tuberculosis infection.
    Zhou Y; Lan H; Shi H; Wu P; Zhou Y
    Tuberculosis (Edinb); 2022 Jul; 135():102221. PubMed ID: 35660362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human peripheral blood DNAM-1
    Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
    Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
    Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
    Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
    Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C
    Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
    Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
    J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
    Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
    Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant.
    Song S; Zhi Y; Tian G; Sun X; Chen Y; Qiu W; Jiao W; Huang H; Yu Y; Li M; Lv G
    Liver Transpl; 2023 Aug; 29(8):836-848. PubMed ID: 37002601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome analysis of human CD56
    Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L
    Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation status of CD56
    Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Dysfunctions of CD56
    Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
    Front Immunol; 2021; 12():811091. PubMed ID: 35069597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of KIR
    Di Vito C; Coianiz N; Calvi M; Terzoli S; Zaghi E; Puccio S; Frigo A; Mariotti J; De Philippis C; Mannina D; Sarina B; Mineri R; Le-Trilling VTK; Trilling M; Castagna L; Bramanti S; Santoro A; Mavilio D
    Front Immunol; 2023; 14():1266051. PubMed ID: 38268918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.